Comparative in Vitro Antibacterial Activity of Red Ginger (Zingiber Officinale Var. Rubrum) Extract and Conventional Antibiotics Against Pathogenic Escherichia Coli
Downloads
The increasing incidence of antibiotic resistance in Escherichia coli poses a significant challenge to public health, as the effectiveness of conventional antibiotics such as ciprofloxacin continues to decline due to the emergence of resistant E. coli strains. This study aims to evaluate red ginger extract's in vitro antibacterial activity against Escherichia coli and determine the optimal concentration for bacterial inhibition. This research aims to determine the effectiveness of red ginger extract with concentrations of 60%, 80% and 100% on the growth of Escherichia coli. Research method using a laboratory-based experimental study was conducted using red ginger extract prepared via ethanol maceration at concentrations of 60%, 80%, and 100%. The extract's antibacterial activity against E. coli was evaluated using the disc diffusion method following CLSI guidelines, with ciprofloxacin (500 mg) as a positive control and 95% ethanol as a negative control. Each treatment was replicated five times. Inhibition zones were measured after 24 hours of incubation at 37°C. The results of the study show that red ginger extract demonstrated significant antibacterial activity against E. coli, with mean inhibition zones of 6.08 ± 0.98 mm, 6.48 ± 1.21 mm, and 5.20 ± 1.89 mm for 60%, 80%, and 100% concentrations, respectively. The 80% concentration showed optimal inhibition activity, while the higher concentration (100%) demonstrated reduced effectiveness. Statistical analysis confirmed significant treatment differences (p < .001, η² = 0.967). The positive control produced significantly larger inhibition zones (23.16 ± 1.67 mm, p < .05). This study concludes that red ginger extract exhibits moderate antibacterial activity against E. coli in vitro, with 80% concentration showing optimal efficacy. These findings suggest potential applications in developing natural antimicrobial agents, although further research is needed to elucidate mechanisms of action and evaluate clinical applications.
Copyright (c) 2025 Isramilda Isramilda, Andi Ipaljri, Kinanthi Amalia Putri (Author)
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlikel 4.0 International (CC BY-SA 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
